USP Seeks Input as It Works to Update 1,700 Monographs by 2020
This article was originally published in The Gold Sheet
USP has further accelerated efforts to bring its book of standards up to date by setting a deadline and increasing its investment. Generics firms will need to watch closely in case USP proposes new standards they can’t meet.
You may also be interested in...
Agency may share outcomes of remote record reviews in lieu of inspections at US and foreign facilities.
Emerging global standard could speed testing of biologics and gene therapies for stray viral particles, while sparing laboratory animals.
Guidance from the FDA urges a focus on restarting production, easing drug shortages and completing quality assurance activities for quarantined batches when the coronavirus pandemic recedes.